Christopher Adams
Chief Executive Officer Andarix Pharmaceuticals.
Christopher P. Adams is a visionary entrepreneur in the biotech and life sciences sector, serving as Founder and CEO of Andarix, which develops radiolabeled therapies for cancer. He has founded and co-founded multiple life science and technology companies in Massachusetts, addressing unmet medical needs across areas including obesity therapeutics, eye disease detection, genomics for colon cancer, and cornea wound treatment now considered standard of care. With over 20 issued U.S. and international patents and technologies used in more than 4 million patients worldwide, Adams blends scientific expertise and entrepreneurial acumen to advance innovative medical solutions and drive impact in the biotech industry.
Seminars
- Translating α-emission into clinically meaningful tumor control for metastases
- Overcoming production, stability, and in vivo deastatination challenges to enable reliable imaging, dosimetry, and therapy
- Optimizing dose delivery, safety, and realworld scalability
